> The researchers estimate that for every 10,000 people treated in a year, between 1.5 and 2.5 _extra_ cases will be seen.
The existing rate is about 2 per 10,000 people per year:
> Both Danish studies show that the risk of developing NAION for the individual patient receiving treatment with Ozempic is only 0.2 per thousand per year, which is fortunately significantly lower than in the American study. NAION is a relatively rare condition, and the extra risk is therefore low.
> The researchers estimate that for every 10,000 people treated in a year, between 1.5 and 2.5 _extra_ cases will be seen.
The existing rate is about 2 per 10,000 people per year:
> Both Danish studies show that the risk of developing NAION for the individual patient receiving treatment with Ozempic is only 0.2 per thousand per year, which is fortunately significantly lower than in the American study. NAION is a relatively rare condition, and the extra risk is therefore low.